Connect:        


All Releases
View Summary FDA Accepts for Filing Intellipharmaceutics' ANDA for Generic Seroquel XR®
May 3, 2011
PDF 13.3 KB Add to Briefcase
View Summary Intellipharmaceutics to Webcast Presentation at the Taglich Brothers 8th Annual Small Cap Equity Conference
Apr 27, 2011
PDF 13.6 KB Add to Briefcase
View Summary Intellipharmaceutics Announces First Quarter 2011 Results
Apr 14, 2011
PDF 29.8 KB Add to Briefcase
View Summary Intellipharmaceutics Provides Additional Update on Activities Related to 30mg Generic Version of Focalin XR(R)
Apr 5, 2011
PDF 14.6 KB Add to Briefcase
View Summary Intellipharmaceutics Files ANDA With FDA for Generic Seroquel XR(R)
Apr 4, 2011
PDF 14.0 KB Add to Briefcase
View Summary Intellipharmaceutics Provides Update on Activities Related to 30mg Generic Version of Focalin XR(R)
Mar 29, 2011
PDF 14.6 KB Add to Briefcase
View Summary Intellipharmaceutics Announces 2010 Year End Results
Feb 28, 2011
PDF 27.1 KB Add to Briefcase
View Summary Intellipharmaceutics Expands Drug Commercialization Expertise
Feb 7, 2011
PDF 15.2 KB Add to Briefcase
View Summary Intellipharmaceutics Completes Previously Announced Financing
Feb 1, 2011
PDF 13.0 KB Add to Briefcase
View Summary Intellipharmaceutics Regains NASDAQ Compliance
Jan 26, 2011
PDF 12.7 KB Add to Briefcase
View Summary Intellipharmaceutics Announces US$12,000,000 Financing
Jan 21, 2011
PDF 16.9 KB Add to Briefcase
View Summary Intellipharmaceutics to Open Market at Toronto Stock Exchange on January 27
Jan 11, 2011
PDF 12.9 KB Add to Briefcase
View Summary Intellipharmaceutics Receives Extension of NASDAQ Compliance Deadline
Dec 29, 2010
PDF 13.2 KB Add to Briefcase
View Summary Intellipharmaceutics Provides Update for Its Generic Protonix(R) Application
Dec 22, 2010
PDF 14.9 KB Add to Briefcase
View Summary Intellipharmaceutics Files ANDA With FDA for 30 mg Focalin XR(R)
Dec 7, 2010
PDF 13.3 KB Add to Briefcase
View Summary Intellipharmaceutics Appoints New CFO
Nov 10, 2010
PDF 13.0 KB Add to Briefcase
View Summary Intellipharmaceutics NASDAQ Update and Corporate Matters
Nov 2, 2010
PDF 14.3 KB Add to Briefcase
View Summary Video Interview: Dr. Isa Odidi, CEO, Intellipharmaceutics International Inc. (IPCI)
Nov 1, 2010
PDF 13.1 KB Add to Briefcase
View Summary Intellipharmaceutics International Inc. (IPCI) Chief Executive Officer to Ring The NASDAQ Stock Market Opening Bell
Oct 21, 2010
PDF 10.5 KB Add to Briefcase
View Summary FDA Accepts for Filing Intellipharmaceutics' ANDA for Generic Protonix(R)
Oct 18, 2010
PDF 13.7 KB Add to Briefcase
Showing 121-140 of 159 Page: 1 ... 5 6 7 8  Previous 20 | Next 20
=add release to Briefcase